Georgia BioEd Completes Inaugural Rural Teacher Training Initiative

The Georgia BioEd Institute, together with Georgia Youth Science and Technology Centers and the Georgia Department of Education, hosted the inaugural Rural Teacher Training Initiative (RTTI) at UGA’s Griffin Campus on January 13 th and 14 th , 2020.

Seventy-two science teachers in 7th through 12th grade representing 40 Georgia school districts participated. More than 10,000 students in rural Georgia communities stand to benefit. The curriculum for the two-day symposium is based on Georgia life science industry needs and is aligned with Georgia Standards of Excellence as well as the Technical College System of Georgia’s biotechnology programs. Educators practiced new, hands-on, biotech laboratory activities to take back to their classrooms. They connected with industry leaders and recruiters while also collecting contributed laboratory equipment from our industry partners.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The GaBioEd Institute will deliver the balance of all materials necessary to implement the hands-on lab activities to the participant educators. Teachers are now part of an ongoing learning community that regularly meets with their cohort and master instructor throughout the school year for continued support.

“Hands-on teaching takes practice, courage, preparation, and resources,” said RTTI Director Kristin Boscan. “Our goal is to eliminate obstacles to life science education and careers through training, support and equipment supplementation.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The symposium included an “industry fair” to inform educators about the life science industry in their own backyard, better equipping them to inspire and direct students to successful and frequently lucrative life science careers. The industry fair will certainly foster relationships that lead to industry tours, school field trips and internships.

“You can’t strive towards what you don’t know about,” said Ayesha Okaiwele, a science teacher in the Houston County School System. “When students hear the phrase ‘agriculture careers’ they often think that means farming and becoming a farmer. When, in fact, there’s the technical side of agriculture which involves laboratory work.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia’s life science industry experienced a 14.9 percent growth in employment from 2007 to 2017, according to the 2019 Georgia Life Sciences State of the Industry Report. Maria Saporta further wrote for the Atlanta Business Chronicle, “The report identified 1,960 unique life science establishments that contributed 68,300 jobs and $10 billion to Georgia’s gross domestic product. When including the multiplier effects, the industry supports a total of about 194,000 jobs, and it contributes $21.8 billion to Georgia’s GDP.”

However, researchers at Georgia Tech found just 4.6 percent of Georgia high schools offer the full biotechnology pathway. They also found that less than one half of one percent of Georgia’s 12th grade students completed the final course in that pathway. This demonstrates a clear need for additional education and workforce development.

In addition to financial and in-kind funding from life science companies in Georgia, the state allocated $323,000 in 2019 for the inaugural program including lab implementation and ongoing support. Georgia BioEd is working to secure state funding during the 2020 legislative session to ensure the program continues on an annual basis.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

“The best thing we can do here in Georgia is to create an ecosystem that continues to allow for a growing economy, a talented workforce and significant potential in front of it,” Lt. Governor David Duncan told Georgia Bio last year.

Interested educators can subscribe to the RTTI outreach list and monthly newsletter by emailing mheaphy@gabio.org

“We are grateful to our board members, industry supporters and state leaders for providing the support needed to ensure Georgia can generate the future workforce for the state’s $21 billion life science industry,” Boscan said.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia Bio expresses our gratitude to the following state legislative leadership for helping to make this valuable initiative real to the benefit of all Georgians: Governor Brian Kemp, Lt. Governor Geoff Duncan, House Appropriations Chairman Terry England, Senate Appropriations Chairman Jack Hill, House Appropriations Education Subcommittee Chairman Robert Dickey, Senate Appropriations Education Subcommittee Chairman Ellis Black, Senate Agriculture Chairman John Wilkinson, and House Ethics Chairman Randy Nix.

***

Georgia Bio and the Georgia BioEd Institute would like to thank supporters of the inaugural RTTI Program.

Champions

  • Accenture
  • Annette and Denny Ivey
  • Avantor/VWR  
  • BioRad
  • Dendreon
  • Lab Design and Supply
  • MedShare
  • Sorbtech
  • Takeda
  • The Pipette Solution
  • ThermoFisher
  • Waypoint Analytical

Key Supporters

  • Beate Lloyd
  • Boehringer-Ingelheim
  • Cell Manufacturing Technologies
  • Emory University
  • Georgia Association of Water Professionals
  • Georgia Department of Agriculture
  • Georgia Department of Education
  • Georgia Poultry Laboratory Network
  • Georgia Power
  • Georgia State University
  • Georgia Tech
  • Georgia Youth Science and Technology Centers
  • Gerresheimer
  • Global Center for Medical Innovation
  • GSU BioBus
  • Kennesaw State University
  • Morehouse School of Medicine
  • Quest Diagnostics
  • Recro Gainesville
  • TCSG – Athens Tech
  • UGA – Griffin and Young Scholars’ Program
  • UGA’s Bioexpression and Fermentation Facility
Inaugural Rural Teacher Training Initiative (RTTI) participants 2020
April 30, 2026
BioMADE Announces $21.4 Million Invested in 14 Projects to Develop the U.S. Bioindustrial Manufacturing Industry and Advance National Security Priorities
April 17, 2026
April 17, 2026 - Nutrivert Inc., a developer of non-antibiotic replacements for antibiotic growth promoters in livestock, today announced it has completed the first close, raising $2.375 million, of its Series A-2 funding round of $6 million. The round was led by global animal health investor Arrow Ventures with participation from other investors. The funding will be used to further develop Nutrivert’s manufacturing, human food safety and target animal safety and efficacy packages for the company’s lead product Nutrivert LDPP. Nutrivert LDPP is a proprietary, novel, orally available, lipidated synthetic enantiomeric desmuramyl analog of muramyl dipeptide, the smallest conserved immunoactive component of bacterial peptidoglycan. LDPP has no antibacterial effect but has consistently promoted growth and improved feed efficiency in pig studies. LDPP binds to the mammalian NOD2 receptor and is the only NOD2 ligand reported to inhibit the inflammatory signal NF-κB. In pilot studies, LDPP rescued 70kg pigs from an otherwise lethal dose of porcine reproductive and respiratory syndrome virus (PRRSV) and abrogated influenza disease symptoms in piglets. The Company intends to develop LDPP for all major livestock species worldwide. Patents have been granted in most major markets. The global antibiotic growth promoter market is worth an estimated $5.8 billion. Approximately 73% of all antibiotics are fed to livestock. The market is believed to be the world’s largest drug market by volume, with ~100,000 tons of active pharmaceutical ingredient administered annually. FDA’s latest data, for 2024, show a 13% rise in U.S. livestock antibiotic use since 2017. The Food and Agriculture Organization reports that livestock antibiotics are mostly given to speed animal growth. Regulators and non-governmental organizations have called for reduction of antibiotic use in livestock, citing concerns that the global, intensive use of antibiotics, often at subtherapeutic doses, selects for antimicrobial resistance: bacteria that are “immune” to antibiotics and that therefore pose a threat to public health. Spillovers of antibiotic-resistant bacteria from livestock to humans have been documented. “Nutrivert LDPP has consistently improved feed efficiency in pigs without antibiotics,” said Bernhard Kaltenboeck, CSO. “We are excited to have the support of Arrow Ventures and our other investors in bringing a new tool that will help producers reduce production costs and reduce selection pressure for antimicrobial resistance.” About Nutrivert LDPP: LDPP is an investigational compound currently undergoing clinical evaluation. It has not been approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other global regulatory authority for any indication. The safety and efficacy of LDPP have not been established. Any mention of potential use is based on preliminary data and does not guarantee future regulatory clearance or commercial availability.
April 16, 2026
[Seattle, WA] April 15, 2026 – Apprenti, the leading national intermediary for Registered Apprenticeship (RA), is proud to announce the formal approval and filing of the National Biomanufacturing Technician Standards with the U.S. Department of Labor (USDOL). Crafted under the strategic guidance of the Apprenti Life Science Advisory Board—which includes leaders from Pfizer, Merck, Thermo Fisher, and Biogen—these standards were developed in close partnership with the Life Sciences Workforce Collaborative (LSWC) and InnovATEBIO as part of a high-impact NIIMBL project. This approval represents a foundational shift for the industry, moving away from a fragmented, state-by-state approach to a scalable, consistent model for developing biomanufacturing professionals at sites across all 50 states. The national standards provide a “plug-and-play” framework that ensures a technician trained in Massachusetts or North Carolina meets the same rigorous, industry-vetted benchmarks as one in Ohio or Missouri. The foundational development of these national standards was informed by existing Life Science RA programs from organizations across the country, including: MassBioEd, Oregon Life Sciences, National Center for Therapeutics Manufacturing (NCTM), BioSTL, Wistar Institute, North Carolina Life Sciences Apprenticeship Consortium (NCLSAC) and others. A National Engine for Talent: The filing of these standards is a cornerstone of NIIMBL’s efforts to strengthen domestic biomanufacturing capabilities and develop the workforce of the future. Beyond the standards themselves, the project is delivering a suite of resources and tools—including a comprehensive Employer Toolkit and specialized screening rubrics—that state-based organizations and employers can leverage to implement RA programming for their most in-demand roles. “These national standards set the stage for a sustainable, skills-first pipeline that mirrors the rigor of the industry’s most complex manufacturing processes,” said Daniel Weagle, Director of Life Science Business Development at Apprenti. “By providing a unified approach, we are empowering national employers to scale their workforce development efforts strategically and accessibly.” The Value Proposition of Registered Apprenticeship For Life Science employers, the Registered Apprenticeship model offers a compelling business case rooted in cost-effectiveness and long-term stability: High Retention: RA programs boast exceptional retention rates—historically as high as 89% to 90%—as apprentices are trained within a company’s specific culture and protocols from day one. Cost Efficiency: Research indicates that for every dollar spent on apprenticeship, employers see an average return of $1.47 in increased productivity and reduced recruitment costs. Inclusive Innovation: The model expands access to untapped talent pools, including non-degreed individuals and career-switchers, ensuring the biomanufacturing workforce reflects the demographics of the communities it serves. As the global biopharmaceutical market is projected to exceed $570 billion by 2032 , this partnership between Apprenti, NIIMBL, and industry leaders ensures that the U.S. workforce is not just prepared for the future of manufacturing, but is actively driving it. This project was developed with an award from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and financial assistance from the U.S. Department of Commerce, National Institute of Standards and Technology (70NANB21H086). About Apprenti: Apprenti is a 501(c)(3) nonprofit organization and a U.S. Department of Labor recognized Intermediary. Apprenti designs and delivers scalable Registered Apprenticeship (RA) programs in high-demand industries. By adapting the proven apprenticeship model, Apprenti helps employers meet workforce needs while training the next generation of skilled professionals. Apprenti’s programs are industry-recognized, federally approved, and supports employers across the country. Since launching in 2015, Apprenti has partnered with employers, government agencies, and education providers to create new apprenticeship pathways. About NIIMBL The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of industry standards, and educate a world-leading workforce. Media Contact: Dan Maiese, Communications Manager, dmaiese@niimbl.org , 302-831-3824 About the Life Sciences Workforce Collaborative (LSWC) The Life Sciences Workforce Collaborative (LSWC) is a national nonprofit coalition of state, regional and national life science associations and institutes who are working together to build a competitive, and future-ready life sciences workforce. Originally founded in 2012 as the Coalition of State Bioscience Institutes (CSBI), LSWC connects industry, academia, and government partners through data-driven insights, best practice sharing, and collaborative programs. Learn more at www.LifeSciencesWorkforce.org About InnovATEBIO InnovATEBIO is a National Center for Biotechnology Education, working to advance the education of highly skilled technicians for the nation’s biotechnology workforce. Toward this goal, InnovATEBIO provides leadership in biotechnology technician education, including support for development and sharing of best practices and emerging technologies in biotechnology workforce development. Read LSWC's full announcement here.
MORE POSTS